AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastructure for Translational Medicine) are pleased to announce the signing of a collaboration agreement aimed at fostering actionable scientific and educational cooperation. Continue reading
Category Archives: AZBio News
Drug Discovery Summit catalyst for new approaches and therapies
Academic researchers and industry professionals will discuss drug development at the Fifth Annual Arizona Drug Discovery and Development Summit during Arizona Bioscience WeekContinue reading
Jazz Pharmaceuticals Announces Key Update to Leadership Team
Renée Galá promoted to President and Chief Operating Officer
National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core
PHOENIX (September 14, 2023) – Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This innovative basic, translational, and clinical research center will occupy the entire 7th floor of 850 PBC, comprising approximately 35,000 square feet.Continue reading
Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity
Brand and visual identity demonstrate the best of Johnson & Johnson’s care and humanity, while capturing the Company’s passion and determination to improve the health of people worldwide
CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season
CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.Continue reading
C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA Resource
The Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development.Continue reading
Arizona Tech Investors Gears Up Its 14th Season with a Strong Lineup of Investment Opportunities
As we launch our 14th season, we are excited to continue our mission of fostering innovation, growth, and collaboration within Arizona’s tech landscape.”- Bob DeLean
Continue reading
Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe Depression
Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe DepressionContinue reading
TissueCypher® Provides Clinically-Impactful Risk Stratification in Patients with Barrett’s Esophagus
The TissueCypher Barrett’s Esophagus test can identify patients at a higher or lower risk of developing esophageal cancer than indicated by pathologic diagnoses and clinical risk factors to guide escalated or de-escalated patient management.Continue reading